Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ACADIA Pharmaceuticals Inc.

TRADE

NASDAQ: ACADHealthcare / Biotechnology / USA
21.41+1.56+7.86%Vol 5 213 5641Y Perf -43.08%
Sep 25th, 2018 16:00
BID21.38 ASK21.45
Open20.09 Previous Close19.85
Pre-Market- After-Trading21.62
 - -%  0.21 0.98%
Target Price
30.13 
Analyst Rating
Strong Buy 1.25
Potencial %
40.73 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-14 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-94 
Growth Ranking
★★★+     55.21
Insiders Shares Cnt. % 3/6/12M
-/-/-91 
Income Ranking
 —    -
Market Cap (mil)2 676 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
30.39 
Earnings Date
6th Nov 2018

Today's Price Range

20.0121.84

 

52wk Range

12.7741.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
48.78%
3 Months
31.35%
6 Months
-9.05%
1 Year
-43.08%
3 Years
-37.31%
5 Years
-18.31%

Quotes

Name / TickerPriceChg.Chg.%
ACAD21.411.56007.86
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.80
Current Ratio 6.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin94.40
EBIT Margin-137.50
EBITDA Margin-136.00
Pre-tax Profit Margin-70 240.70
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 9.52
PS Ratios 13.62
Price to Cash Flow -
Price to Free Cash Flow -14.40
Cash Flow Per Share -1.41
Price to Tangible Book9.70
Book Value per Share2.12
Enterprise Value (in ths.)2 264 530
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-61.00
ROE last 12 Months -73.03
Return on Assets (5Y Avg) -45.11
ROA last 12 Months -64.40
Return on Capital (5Y Avg) -54.80
ROC last 12 Months -74.04
Return on invested Capital Q -22.24
Return on invested Capital Y-67.80
Assets Turnover0.40
Receivables Turnover10.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)185 071
Revenue per Share 1.48
Revenue Growth 3 Years 1 234.80
Revenue Growth 5 Years 184.39
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.45-0.51-13.33
Q01 2018-0.56-0.4421.43
Q04 2017-0.58-0.555.17
Q03 2017-0.63-0.5315.87
Q02 2017-0.71-0.5522.54
Q01 2017-0.73-0.721.37
Q04 2016-0.65-0.650.00
Q03 2016-0.55-0.61-10.91
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.58-52.63Negative
12/2018 QR-0.53-55.88Negative
12/2018 FY-2.10-22.81Negative
12/2019 FY-1.55-162.71Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.58
Estimates Count6
EPS Growth Next 5 Years %22.50
Volume Overview
Volume5 213 564
Shares Outstanding (in ths.)125 010
Trades Count19 960
Dollar Volume100 892 446
Avg. Volume2 849 079
Avg. Weekly Volume7 982 965
Avg. Monthly Volume2 986 876
Avg. Quarterly Volume2 980 053

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

44%56%

Bearish Bullish

66%34%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
5 (71.43 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (12.50 %)
2 (28.57 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Moderate Buy
1.57
Strong Buy
1.00

There are no comments yet.

News

x